Myriad Genetics Stock (NASDAQ: MYGN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.00 / 791.55K |
Day Range | - - - |
52 Wk Range | 13.82 - 29.30 |
Market Cap | $2.45B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 6.08% |
Days to Cover | 7.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.
Other companies in Myriad Genetics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
Myriad Genetics has a consensus price target of $27.57.
The stock price for Myriad Genetics (NASDAQ: MYGN) is $26.93 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Myriad Genetics.
Myriad Genetics’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Myriad Genetics.
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.